TR201910497T4 - S-asetil glutatyonun kristal formları, bunların hazırlanması ve farmasötik ve nutrasötik formülasyonlarda kullanımları. - Google Patents

S-asetil glutatyonun kristal formları, bunların hazırlanması ve farmasötik ve nutrasötik formülasyonlarda kullanımları. Download PDF

Info

Publication number
TR201910497T4
TR201910497T4 TR2019/10497T TR201910497T TR201910497T4 TR 201910497 T4 TR201910497 T4 TR 201910497T4 TR 2019/10497 T TR2019/10497 T TR 2019/10497T TR 201910497 T TR201910497 T TR 201910497T TR 201910497 T4 TR201910497 T4 TR 201910497T4
Authority
TR
Turkey
Prior art keywords
pharmaceutical
crystal forms
preparation
nutraceutical formulations
water
Prior art date
Application number
TR2019/10497T
Other languages
English (en)
Inventor
Bianchi Davide
Valetti Marco
Bazza Paola
Original Assignee
Gnosis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gnosis Spa filed Critical Gnosis Spa
Publication of TR201910497T4 publication Critical patent/TR201910497T4/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • C07K1/306Extraction; Separation; Purification by precipitation by crystallization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

Kontrollü koşullar altında su-aseton, su-etanol veya su-metanol karışımlarından, tercihen asetondan SAG'nin kristallendirilmesi ile elde edilen, S-asetil glutatyonun (SAG) Form A ve Form B adı verilen iki kristal formu açıklanmaktadır. Bu kristal formların karakterize edici özelliği, X-ışını toz kırınımı, IR spektrumu ve DSC'sidir. Formlar A ve B, farmasötik veya nutrasötik formülasyonların içerik maddeleri olarak avantajlı bir şekilde kullanılabilir.
TR2019/10497T 2013-11-08 2014-11-06 S-asetil glutatyonun kristal formları, bunların hazırlanması ve farmasötik ve nutrasötik formülasyonlarda kullanımları. TR201910497T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001856A ITMI20131856A1 (it) 2013-11-08 2013-11-08 Processo per la preparazione di differenti forme cristalline del s-acetil glutatione e loro utilizzi in formulazioni farmaceutiche e nutraceutiche

Publications (1)

Publication Number Publication Date
TR201910497T4 true TR201910497T4 (tr) 2019-08-21

Family

ID=49683911

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/10497T TR201910497T4 (tr) 2013-11-08 2014-11-06 S-asetil glutatyonun kristal formları, bunların hazırlanması ve farmasötik ve nutrasötik formülasyonlarda kullanımları.

Country Status (25)

Country Link
US (1) US9834579B2 (tr)
EP (1) EP3066111B1 (tr)
JP (1) JP6534394B2 (tr)
KR (1) KR20160070782A (tr)
CN (1) CN105705512B (tr)
AU (1) AU2014345562B2 (tr)
CA (1) CA2929707C (tr)
CY (1) CY1121811T1 (tr)
DK (1) DK3066111T3 (tr)
EA (1) EA029886B1 (tr)
ES (1) ES2738858T3 (tr)
GE (2) GEP20196957B (tr)
HR (1) HRP20191522T1 (tr)
HU (1) HUE045975T2 (tr)
IL (1) IL245487A0 (tr)
IT (1) ITMI20131856A1 (tr)
LT (1) LT3066111T (tr)
MX (1) MX368816B (tr)
PH (1) PH12016500832A1 (tr)
PL (1) PL3066111T3 (tr)
RS (1) RS59101B1 (tr)
SI (1) SI3066111T1 (tr)
TR (1) TR201910497T4 (tr)
UA (1) UA120257C2 (tr)
WO (1) WO2015067708A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107227220A (zh) * 2016-03-23 2017-10-03 百瑞全球有限公司 制备含有s-乙酰基谷胱甘肽的发酵酒的方法
EP3560947B1 (en) 2016-12-20 2022-08-24 Kyowa Hakko Bio Co., Ltd. Crystal of glutathione trisulfide dihydrate and method for producing same
CN114605491B (zh) * 2022-03-24 2024-02-06 安庆辰泰生物科技有限公司 S-乙酰-l-谷胱甘肽的制备方法以及混合溶剂的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB761093A (en) * 1954-03-31 1956-11-07 Distillers Co Yeast Ltd Production of s-acetyl glutathione
DE3722647A1 (de) * 1987-07-09 1989-01-19 Gerhard Ohlenschlaeger Galenische verwendung eines tripeptids als arzneimittel
IT1248994B (it) * 1990-06-26 1995-02-11 Co Ri T S A S Di Buoso Maria & Processo per la preparazione di s-acil derivati di glutatione composti ottenuti da detto processo e intermedio utile per la loro preparazione
EP1874948B1 (en) * 2005-03-31 2013-03-20 NewSouth Innovations Pty Limited Process for the production of y-glutamylcysteine
WO2008144675A1 (en) * 2007-05-17 2008-11-27 Neopro Labs, Llc Crystalline and amorphous forms of peptide
NZ605526A (en) * 2010-07-12 2015-04-24 Celgene Corp Romidepsin solid forms and uses thereof
CN103058922B (zh) * 2012-09-06 2014-07-16 湖南有色凯铂生物药业有限公司 用于抗肿瘤药物的芳香脲的晶型及其制备方法
CN104193800B (zh) * 2014-09-25 2017-01-18 北京德默高科医药技术有限公司 S‑乙酰‑l‑谷胱甘肽的i、ii型晶体

Also Published As

Publication number Publication date
IL245487A0 (en) 2016-06-30
DK3066111T3 (da) 2019-08-05
NZ719763A (en) 2021-03-26
WO2015067708A1 (en) 2015-05-14
EP3066111B1 (en) 2019-06-05
EA201690735A1 (ru) 2016-10-31
UA120257C2 (uk) 2019-11-11
RS59101B1 (sr) 2019-09-30
ITMI20131856A1 (it) 2015-05-09
HRP20191522T1 (hr) 2019-11-29
CY1121811T1 (el) 2020-07-31
KR20160070782A (ko) 2016-06-20
CA2929707A1 (en) 2015-05-14
AU2014345562A1 (en) 2016-05-26
ES2738858T3 (es) 2020-01-27
LT3066111T (lt) 2019-11-25
CN105705512B (zh) 2020-10-16
HUE045975T2 (hu) 2020-01-28
CA2929707C (en) 2022-05-03
EP3066111A1 (en) 2016-09-14
GEAP201814134A (en) 2018-11-26
PH12016500832B1 (en) 2016-06-13
PL3066111T3 (pl) 2019-11-29
JP2017501208A (ja) 2017-01-12
GEP20196957B (en) 2019-03-25
MX368816B (es) 2019-10-17
EA029886B1 (ru) 2018-05-31
SI3066111T1 (sl) 2019-09-30
US20160272677A1 (en) 2016-09-22
JP6534394B2 (ja) 2019-06-26
PH12016500832A1 (en) 2016-06-13
AU2014345562B2 (en) 2018-09-20
MX2016005881A (es) 2016-08-17
CN105705512A (zh) 2016-06-22
US9834579B2 (en) 2017-12-05

Similar Documents

Publication Publication Date Title
CY1124726T1 (el) Παραγωγα κιναζολινης που χρησιμοποιουνται για την αντιμετωπιση του hiv
TR201900360T4 (tr) Valsartan ve ahu-377 i̇çeren tri̇sodyum çok moleküllü kompleksi̇n kri̇stali̇n formlari ve bunun yöntemleri̇
EA201890817A1 (ru) Кристаллические формы бета-никотинамида мононуклеотида
PH12019500188A1 (en) Piperidine cxcr7 receptor modulators
WO2015160843A8 (en) Ion channel activators and methods of use
WO2016014927A3 (en) Crystalline form of nicotinamide riboside
CY1121326T1 (el) Υποκατεστημενη 2,4 διαμινο-κινολινη ως νεοι αντικαρκινικοι παραγοντες
EA201891063A1 (ru) Производные дигидроимидазопиразинона, применимые в лечении рака
EA201591451A1 (ru) Модуляторы flap
PH12016500985A1 (en) Use of benzimidazole-proline derivatives
MX373612B (es) Cristal del compuesto alquinil benceno 3,5-disustituido.
CY1119619T1 (el) Παραγωγα πυριδιν-4-υλιου
CY1119147T1 (el) Νεο αλας toy abexinostat, συναφης κρυσταλλικη μορφη, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τις περιεχουν
TR201906685T4 (tr) Kristalin macitentan içeren farmasötik bileşim.
ECSP16096831A (es) Derivados de naftiridinadiona
BR112017004000A2 (pt) formas cristalinas de 6-((6,7-dimetoxiquinazolin-4-il)óxi)-n,2-dimetilbenzofuran-3-carboxamida
TR201910497T4 (tr) S-asetil glutatyonun kristal formları, bunların hazırlanması ve farmasötik ve nutrasötik formülasyonlarda kullanımları.
WO2017214423A3 (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof
CY1114704T1 (el) Κρυσταλλικη μορφη δ του αλατος αργινινης της περινδοπριλης, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις οι οποιες την περιεχουν
EA201591860A1 (ru) Усилители водорастворимости на основе гликогена
WO2015031198A3 (en) Bendamustine pharmaceutical compositions
BR112015030589A8 (pt) formas polimórficas de fosfato de icotinibe, composição farmacêutica compreendendo as referidas formas e usos das mesmas
WO2016100833A3 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
CY1124392T1 (el) Χρηση σακχαροαλκοολων σε συνθεσεις τιβολονης
CN302216036S (zh) 包装盒(赶黄草)